Inside

Finding the Cures

Wing Leung, MD, PhD and Jeffrey Rubnitz, MD, PhD
Powerful but rare immune cells taken from a parent might provide a safe, effective and affordable approach to preventing cancer’s return in young patients with acute myeloid leukemia (AML), according to new St. Jude research.
 

Basic Science

The diverse research at St. Jude ranges from discovery-focused and hypothesis-testing laboratory studies to clinical trials of specific agents, regimens, or therapeutic interventions. We continually seek to translate knowledge acquired through basic research into novel approaches for clinical diagnosis and treatment. At the same time, our clinical and laboratory-based investigators use the challenges encountered in the clinic to focus the efforts of our research.

The Research Behind the Cures

Thirumala-Devi Kanneganti, PhD

New research details the machinery of immune protection against inflammatory disease like colitis

Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.

Read More

St. Jude's Scientific Report 2009

Scientific Report

Key research activities and publications by the investigators at St. Jude during 2008 are summarized in the Scientific Report 2009.

In the News

Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital and Washington University School of Medicine in St. Louis, today announced an unprecedented effort to identify the genetic changes that give rise to some of the world’s deadliest childhood cancers. The team has joined forces to decode the genomes of more than 600 childhood cancer patients who have contributed tumor samples for this historic effort.

Interactive / Multimedia